Washington: Aspirin, the drug taken by countless people around the world to relief pain and reduce their risk of developing heart disease, may also help prevent cancer.A growing body of evidence suggests that taking aspirin may reduce an individual’s chances of developing colorectal cancer and perhaps other malignancies, but whether that evidence is strong enough to outweigh the risks of prescribing it to millions of healthy people is the subject of debate among researchers at the ESMO 2012 Congress in Vienna.Arguing in favor of the question – “Is aspirin (NSAID) ready for chemoprevention of colorectal adenoma/cancer?” – is Prof Robert Benamouzig from the Department of Gastroenterology, Avicenne Hospital, Bobigny, France.“The efficacy of aspirin in preventing colorectal cancer has been made obvious by more than twenty years of research,” said Prof Benamouzig.“In 2010, researchers published the 20-year follow-up of five pooled randomized trials that assessed the effect of aspirin on colorectal cancer incidence and mortality. The study of more than 14,000 patients found that daily aspirin at any dose reduced risk of colorectal cancer by 24 percent and associated deaths by 35 percent after a delay of about 8 to 10 years.”“In these trials, the reduction of colorectal cancer rates was in essence a side-effect of treatment. None of them had such a reduction as their primary outcome. Nevertheless, the evidence that aspirin is effective for preventing these colorectal cancers is very strong,” Prof Benamouzig stated.
BCCI to restrict WAGs during foreign tours?
Govt bans film on Indira`s assassination
Gujarat: Wife meets lost husband via WhatsApp
Maharashtra CM Prithviraj Chavan not to share dais with Narendra Modi